Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00793000 · ClinicalTrials.gov registry record · Phase 1
Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT00793000 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 80 participants.
The verdict
NCT00793000, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety, tolerability and pharmacokinetics of PF-04287881 after a single oral dose in healthy adult volunteers.
Interventions
- DRUG Placebo
- DRUG PF-04287881
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00793000
The ClinicalTrials.gov registry entry for NCT00793000 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00793000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00793000 about?
NCT00793000 is a clinical study titled "Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults". The purpose of this study is to determine the safety, tolerability and pharmacokinetics of PF-04287881 after a single oral dose in healthy adult volunteers.
What is the current status of trial NCT00793000?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2008-11. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00793000?
The interventions under investigation include: Placebo (DRUG), PF-04287881 (DRUG).
Who is sponsoring clinical trial NCT00793000?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.